In summary, mTOR has less direct means of regulating genetic polymorphisms and epigenetics, and most genetic and epigenetic changes regulate the development of NAFLD through the coregulation of multiple factors. This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.